Global Cancer Dx, Inc.

The Lung Cancer Test is a new proprietary blood test that has been proven through clinical studies to determine the risk of lung cancer in early stages.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Tempe, AZ, US
  • Currency USD
  • Founded 2012
  • Employees 10
  • Website --

Company Summary

Global Cancer Diagnostics Inc. is a privately held CLIA certified diagnostic laboratory company focused on detecting “high death rate lung cancers” in early stages. The Lung Cancer Test screens for lung cancer in the high risk population of smokers and former smokers over the age of 50. The test is affordably priced at $99 plus shipping and handling. The Lung Cancer Test was launched to the public on October 20, 2014.

Team

  • WIll Gartner
    CEO

    William Gartner has 20 issued patents and 35 years of experience in the environmental and medical fields with an extensive history of product development, operational oversight, corporate acquisitions and technology transfer.

  • Patricia Baker DrPH
    Lab Director

    Dr. Patricia Baker created a CAP-accredited, CLIA laboratory while at Diagnostic Laboratories. Dr. Baker has served as director of many other governmental and private labs, including a position as the Indiana State Laboratory Director. GCDx has also assembled a strong list for its Medical Advisory Board.

Advisors

  • Dr. Michael Demeure
    Medical Advisory Board
    Unconfirmed
    Dr. Hirsh Handmaker
    Medical Advisory Board
    Unconfirmed
    Dr. Helen B. Tropzell
    Medical Advisory Board
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free